BizJournals Portfolio

Elan Corporation PLC (ELN)

OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Employees

Number of Employees: 1610
Revenue per Employee: $358,535

Corporate Structure
CHIEF EXECUTIVE OFFICER
G. Kelly Martin
TOP EXECUTIVES
Gary Kennedy      Non-Executive Director
William R. Rohn      Non-Executive Director
Shane Cooke      Executive Director, Chief Financial Officer and Head of Elan Drug Technologies
William F. Daniel      Executive Vice President and Company Secretary
Dr.Lars Ekman, M.D., Ph.D.      Non-Executive Director
Dr.Floyd E. Bloom      Non-Executive Director
Kieran McGowan      Lead Independent Director
Ann Maynard Gray      Non-Executive Director
Kyran McLaughlin      Non-Executive Chairman of the Board
Dr. Ivan Lieberburg, MD, PhD      Executive Vice President and Chief Medical Officer
Dr. Dennis J. Selkoe, MD      Non-Executive Director
Nigel Clerkin      Senior Vice President, Finance and Group Controller
Richard Collier      Executive Vice President and General Counsel
Dr. Allison Hulme, PhD      Executive Vice President, Global Development
Karen S. Kim      Executive Vice President of Corporate Strategy & Alliances, Communications, Branding and Specialty B
Kathleen Martorano      Executive Vice President, Strategic Human Resources
Dr. Dale Schenk, PhD      Executive Vice President and Chief Scientific Officer
Dr.Ted Yednock, PhD      Executive Vice President and Head of Global Research
Dr. David W. Feigal, Jr, MD      Senior Vice President, Head of Global Regulatory and Global Safety Surveillance
Dr. Menghis Bairu, MD      Senior Vice President and Head of International
Jeffrey Shames      Non-Executive Director
Giles Kerr      Non-Executive Director
Jonas Frick      Non-Executive Director
Dr. Johannes Roebers, PhD      Senior Vice President and Head of Biologic Strategy, Planning and Operations
Dr. James Callaway, PhD      Senior Vice President and Head of Immunotherapy AD Clinical Programs